details of europe and cambrex deal

Just an extract from a previous announcement:

“In order to obtain marketing approval, the Belgian authorities will first have to approve the manufacturing process to cGMP standards. Country specific submissions will then take place. While the exact timing of the approval process is dependent on regulatory agencies, we expect to be treating European patients during the first quarter of 2004. By then we will have sales and customer service resources trained and ready to support hospitals in Germany, Austria and Switzerland, with a population of approx. 100 million and thirty burn centres,” said Troels Jordansen said.


+ Does anyone know the details of the contract between C3 and Cambrex? ie Do Cambrex simply manufacture and distribute C3 products?

+ Has anyone got any ideas on the likely revenue, costs, profit numbers? I am assuming this Europe deal will by highly profitable, however seems Australian revenue is a little light?

+ What are the chances of CCE not getting the proper approval?

Fingers crossed this all works out.